Format

Send to

Choose Destination
See comment in PubMed Commons below
Child Adolesc Psychiatr Clin N Am. 2012 Oct;21(4):789-806. doi: 10.1016/j.chc.2012.07.007.

Psychopharmacologic treatment for pediatric anxiety disorders.

Author information

  • 1Department of Psychiatry, Division of Child and Adolescent Psychiatry, Vanderbilt University School of Medicine, Vanderbilt Psychiatric Hospital, Nashville, TN 37212-8645, USA. todd.peters@vanderbilt.edu

Abstract

Anxiety is an innate emotion that all humans experience, especially during early childhood in periods of significant growth and development. Treatment strategies exist for anxiety disorders that cause significant dysfunction and impairment in youth. This article provides a current overview of the literature on psychopharmacologic management of pediatric anxiety disorders. Potential side effects and complications of psychotropic medications are reviewed. The treatment of anxiety disorders in patients with comorbid conditions is explored, addressing the impact on treatment course and pharmacologic recommendations. A clinical vignette describing a 10-year-old boy with increasing anxiety is presented describing in-hospital and outpatient treatment and therapies.

Copyright © 2012 Elsevier Inc. All rights reserved.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk